Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2003
07/24/2003WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059265A2 Compositions and methods for treating heart failure
07/24/2003WO2003059258A2 Compositions and methods for treating heart failure
07/24/2003WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
07/24/2003WO2003046200A3 Methods for ligand discovery
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003WO2003024934A3 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
07/24/2003WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139463 Anticancer agents; antiarthritic agents
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139451 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
07/24/2003US20030139450 Respiratory syncytial virus
07/24/2003US20030139446 Reacting with acid mixed with solvent; salt formation
07/24/2003US20030139436 Stabilized liquid preparation
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139433 Incontinence
07/24/2003US20030139425 Piperazine derivatives and their use as anti-inflammatory agents
07/24/2003US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
07/24/2003US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
07/24/2003US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
07/24/2003US20030139416 Anticancer agents; kidney disease
07/24/2003US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
07/24/2003US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles
07/24/2003US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
07/24/2003US20030139403 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
07/24/2003US20030139390 Compounds for the modulation of PPARgamma activity
07/24/2003US20030139389 Gastrointestinal disorders, cardiovascular disorders, central nervous system disorders
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030139348 Animal growth regulators
07/24/2003US20030138662 A dibenzoquinoxaline compounds electron transporting materials; flat-panel display, electroluminescence
07/24/2003CA2474239A1 Substituted pyridazinones as inhibitors of p38
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2473236A1 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003CA2472395A1 Pantoprazole cyclodextrin inclusion complexes
07/24/2003CA2472377A1 Crystalline solids of carvedilol and processes for their preparation
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2472160A1 Quinazolinone compounds in combined modalities for improved cancer treatment
07/24/2003CA2471620A1 Pyrrolidone carboxamides
07/24/2003CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003CA2469435A1 Modulators of lxr
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329218A1 Preventives/remedies for portal hypertension
07/23/2003EP1329160A2 4-acylaminopyrazole derivatives
07/23/2003EP1328519A2 Orally active salts with tyrosine kinase activity
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
07/23/2003EP1123932B1 Novel anthrapyridone compounds, water-based magenta ink composition, and method of ink-jet printing
07/23/2003EP0775702B1 Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
07/23/2003EP0628033B1 Benzodiazepin derivatives useful as cck-receptor antagonists
07/23/2003CN1432013A Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
07/23/2003CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432011A Benzoamide piperidine compounds as substance P antagonists
07/23/2003CN1432010A 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs
07/23/2003CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432008A Quinolonecarboxylic acid derivative
07/23/2003CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion
07/23/2003CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators
07/23/2003CN1432001A 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
07/23/2003CN1432000A TNF-alpha prodn. inhibitors
07/23/2003CN1431998A Growth hormone secretagogues
07/23/2003CN1431997A 2-acyl indol derivatives and their use as anti-tumour agents
07/23/2003CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
07/23/2003CN1115339C Novel sulfonylaminopyrimidines
07/23/2003CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator
07/23/2003CN1115333C Method for producing 2-sulfonylpyridine derivatives and method for producing 2-´¢øÒÇö(2-pyridyl)methylÒÇòthio´¢Ø-1H-benzimidazole derivatives
07/22/2003US6596876 Prostaglandin I2 inhibitors
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596871 Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
07/22/2003US6596867 Bone disorders
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596773 Central nervous system disorders
07/22/2003US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are
07/22/2003US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
07/22/2003US6596749 Neuropeptide y receptor ligand
07/22/2003US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I):
07/22/2003US6596735 Compounds and to the use of said compounds for inhibiting abnormal cell growth in mammals. The compounds of the above formula have activity as farnesyl protein transferase inhibitors. for treatment of cancer andhyperproliferation
07/22/2003US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
07/22/2003US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients
07/22/2003US6596727 Substituted pyrimidines, processes for their preparation, and their use as pesticides and fungicides
07/22/2003US6596723 Fungal efflux pump inhibitors
07/22/2003US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides
07/22/2003US6596715 Protease inhibitors
07/22/2003CA2294422C Tartrate salt of a substituted dipeptide
07/22/2003CA2276203C N-(pyridinylamino)isoindolines and related compounds
07/22/2003CA2275602C Novel carboxy substituted cyclic carboxamide derivatives
07/22/2003CA2239603C Quinolines and quinazolines useful in therapy
07/17/2003WO2003058667A1 Organic light-emitting devices
07/17/2003WO2003057690A1 Indolinone derivatives useful as protein kinase inhibitors
1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 1080